單細胞體學市場規模、佔有率和成長分析：按技術、產品、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球單細胞體學市場價值為 48.2 億美元，預計到 2033 年將從 2025 年的 56.1 億美元成長至 188.5 億美元，在預測期（2026-2033 年）內複合年成長率為 16.32%。

全球單細胞體學市場正迅速發展，一系列旨在分析單一細胞層面的基因組、轉錄組、表觀基因和蛋白質組的先進技術正日益受到關注。這項創新滿足了傳統批量檢測方法常常忽略的細胞異質性的需求，從而能夠更深入地了解細胞多樣性，並最終應用於關鍵的臨床領域，例如識別腫瘤微環境中的抗藥性克隆以及增強免疫分析以改進查核點抑制劑療法。關鍵進展包括向高通量液滴定序和多模態平台的轉變。更低的單樣本成本提高了學術界和工業界的可及性，刺激了製藥業的投資。這一趨勢正在推動單細胞分析融入生物製藥的基礎運營，從而推動診斷和個人化醫療的發展。

全球單細胞體學市場按技術、產品、應用、最終用戶和地區進行細分。依技術分類，市場分為單細胞基因組學、單細胞轉錄組學（scRNA-seq）、單細胞蛋白質組學和單細胞表觀基因。依產品分類，市場分為儀器、試劑盒及軟體及生物資訊學。依應用分類，市場分為腫瘤學、免疫學、神經科學和發育生物學。依最終用戶分類，市場分為研究機構、製藥和生物技術公司以及合約研究組織（CRO）。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球單細胞體學市場成長要素

單細胞定序、微流體技術和影像技術的快速發展顯著提高了單細胞體學工作流程的可及性和靈敏度。這些進步使研究人員能夠更可靠地研究單一細胞，降低技術難度，提高樣本處理能力，並擴大生物學研究的範圍。這些能力的提升和試劑品質的提高預計將推動相關人員對單細胞解決方案的更多投資。這種日益成長的興趣預計將推動市場成長，因為學術界、臨床和工業界對各種系統、耗材和服務的需求都在增加。

全球單細胞體學市場面臨的限制因素

購置最先進的單細胞定序設備、專用微流體技術和高品質試劑需要大量的資金投入，這對各種研究和臨床環境構成了重大障礙。耗材和設備維護的持續成本會給小規模​​的研究機構以及位於發展中地區的機構帶來沉重的預算負擔。這些經濟限制減緩了科技的普及速度，往往導致人們更傾向於集中式服務模式而非廣泛的內部部署。因此，潛在客戶推遲或放棄購買，轉而選擇透過共用設施或外部服務供應商來滿足自身需求，從而阻礙了市場成長。

全球單細胞體學市場趨勢

全球單細胞體學市場正經歷需求的激增，這主要得益於整合多組體學工作流程的日益普及。研究人員和生物製藥公司越來越傾向於尋求涵蓋單細胞基因組學、轉錄組學、蛋白質組學和表觀基因的綜合解決方案，以期在最大限度減少樣本損失的同時，獲得更深入的生物學見解。這種轉變正推動供應商不斷創新，開發可互通的儀器和標準化試劑，從而簡化複雜的實驗設計和跨模態數據解讀。此外，技術開發人員和應用科學家之間日益密切的合作正在加速轉化研究，顯著影響藥物發現、診斷和精準醫療，進而改變生物醫學研究的格局。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球單細胞體學市場規模：依技術分類

• 單細胞基因體學
• 單細胞轉錄組學（scRNA-seq）
• 單細胞蛋白質體學
• 單細胞表觀基因

全球單細胞體學市場規模：依產品分類

• 裝置
• 試劑和試劑盒
• 軟體與生物資訊學

全球單細胞體學市場規模：按應用領域分類

• 腫瘤學
• 免疫學
• 神經科學
• 發育生物學

全球單細胞體學市場規模：依最終用戶分類

• 研究機構
• 製藥和生物技術
• CRO

全球單細胞體學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• 10x Genomics
• Illumina Inc.
• Thermo Fisher Scientific
• Fluidigm Corporation
• Bio-Rad Laboratories
• Becton Dickinson
• Miltenyi Biotec
• Parse Biosciences
• Vizgen Inc.
• NanoString Technologies
• Akoya Biosciences
• Singlera Genomics
• Mission Bio
• Cellenics
• Curio Bioscience
• Scale Biosciences
• Honeycomb Biotechnologies
• Singular Genomics
• Aspect Biosystems
• Berry Genomics

結論與建議

Global Single-Cell Omics Market size was valued at USD 4.82 Billion in 2024 and is poised to grow from USD 5.61 Billion in 2025 to USD 18.85 Billion by 2033, growing at a CAGR of 16.32% during the forecast period (2026-2033).

The global single-cell omics market is rapidly evolving, showcasing a range of advanced technologies designed to analyze genomes, transcriptomes, epigenomes, and proteomes at the individual cell level. This innovation addresses the need to reveal cellular heterogeneity often masked by traditional bulk assays, facilitating a deeper understanding of cell variations that can translate into significant clinical applications, such as identifying drug-resistant clones within tumor microenvironments and enhancing immune profiling for better checkpoint inhibitor therapies. Key advancements include the transition to high-throughput droplet sequencing and multimodal platforms. The decline in costs per sample has broadened accessibility for academia and industry alike, encouraging pharmaceutical investments. This trend supports the integration of single-cell profiling into fundamental biopharma operations, promoting advancements in diagnostics and personalized medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single-Cell Omics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single-Cell Omics Market Segments Analysis

Global single-cell omics market is segmented by technology, product, application, end-user and region. Based on technology, the market is segmented into single-cell genomics, single-cell transcriptomics (scRNA-seq), single-cell proteomics and single-cell epigenomics. Based on product, the market is segmented into instruments, reagents & kits and software & bioinformatics. Based on application, the market is segmented into oncology, immunology, neuroscience and developmental biology. Based on end-user, the market is segmented into research institutes, pharma & biotech and CROs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Single-Cell Omics Market

The rapid advancement of single-cell sequencing technologies, microfluidics, and imaging methods has significantly enhanced the accessibility and sensitivity of single-cell omics workflows. This progress allows researchers to investigate individual cells more confidently, reducing technical challenges, boosting sample throughput, and broadening the scope of biological inquiries. As these capabilities improve and the quality of reagents rises, there is an anticipated increase in stakeholder investment in single-cell solutions. This heightened interest is expected to propel market growth, driven by rising demand for various systems, consumables, and services across academic, clinical, and industrial sectors.

Restraints in the Global Single-Cell Omics Market

The considerable financial investment required for cutting-edge single-cell sequencing equipment, specialized microfluidic technologies, and premium reagents poses a significant obstacle for various laboratories and clinical environments. Ongoing expenses related to consumables and instrument upkeep can strain the budgets of smaller research institutions and those located in developing regions. These economic limitations hinder the pace of adoption, often leading to a preference for centralized service models rather than broader in-house implementation. Consequently, market growth is stifled as potential customers choose to delay or bypass purchases, opting instead for shared facilities or external service providers to meet their needs.

Market Trends of the Global Single-Cell Omics Market

The Global Single-Cell Omics market is witnessing a surge in demand fueled by the growing adoption of integrated multi-omics workflows. Researchers and biopharma companies are increasingly seeking comprehensive solutions that encompass single-cell genomics, transcriptomics, proteomics, and epigenomics, enabling deeper biological insights while minimizing sample loss. This shift is prompting vendors to innovate by creating interoperable instruments and standardized reagents, facilitating complex experimental designs and cross-modal data interpretation. Additionally, enhanced collaboration between technology developers and application scientists is accelerating translational research, significantly impacting drug discovery, diagnostics, and precision medicine initiatives, thereby reshaping the landscape of biomedical research.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Single-cell Omics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Single-Cell Genomics
• Single-Cell Transcriptomics (scRNA-seq)
• Single-Cell Proteomics
• Single-Cell Epigenomics

Global Single-cell Omics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Kits
• Software & Bioinformatics

Global Single-cell Omics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Immunology
• Neuroscience
• Developmental Biology

Global Single-cell Omics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Research Institutes
• Pharma & Biotech
• CROs

Global Single-cell Omics Market Size & CAGR (2026-2033)

• North America (Technology, Product, Application, End-User)
  • US
  • Canada
• Europe (Technology, Product, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parse Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vizgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akoya Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singlera Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mission Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellenics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curio Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scale Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Honeycomb Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singular Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspect Biosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berry Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations